Compare PPL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PPL | GEHC |
|---|---|---|
| Founded | 1920 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Computer Software: Prepackaged Software |
| Sector | Utilities | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 27.9B |
| IPO Year | 2007 | 2022 |
| Metric | PPL | GEHC |
|---|---|---|
| Price | $34.21 | $71.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $41.08 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 7.5M | 3.0M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.95% | 0.24% |
| EPS Growth | ★ 32.50 | 4.84 |
| EPS | ★ 1.59 | 0.85 |
| Revenue | $9,042,000,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $7.23 | $7.12 |
| Revenue Next Year | $5.85 | $4.45 |
| P/E Ratio | ★ $21.66 | $85.27 |
| Revenue Growth | ★ 6.85 | 4.84 |
| 52 Week Low | $33.17 | $58.75 |
| 52 Week High | $40.11 | $89.77 |
| Indicator | PPL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 40.00 | 55.39 |
| Support Level | $34.47 | $69.17 |
| Resistance Level | $36.89 | $73.51 |
| Average True Range (ATR) | 0.55 | 1.32 |
| MACD | -0.08 | -0.37 |
| Stochastic Oscillator | 4.94 | 28.56 |
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).